<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Choi EB</submitter><funding>National Research Foundation of Korea</funding><pagination>13512</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9656104</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(21)</volume><pubmed_abstract>Bone absorption is necessary for the maintenance of bone homeostasis. An osteoclast (OC) is a monocyte-macrophage lineage cell that absorbs bone tissue. Extracellular signal-regulated kinases (ERKs) are known to play important roles in regulating OC growth and differentiation. In this study, we examined specific downstream signal pathways affected by ERK inhibition during OC differentiation. Our results showed that the ERK inhibitors PD98059 and U0126 increased receptor activator of NF-κB ligand (RANKL)-induced OC differentiation in RAW 264.7 cells, implying a negative role in OC differentiation. This is supported by the effect of ERK2-specific small interfering RNA on increasing OC differentiation. In contrast to our findings regarding the RAW 264.7 cells, the ERK inhibitors attenuated th</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>ERK Inhibition Increases RANKL-Induced Osteoclast Differentiation in RAW 264.7 Cells by Stimulating AMPK Activation and RANK Expression and Inhibiting Anti-Osteoclastogenic Factor Expression.</pubmed_title><pmcid>PMC9656104</pmcid><funding_grant_id>2020R1F1A1068065 and 2022R1I1A1A01055015</funding_grant_id><pubmed_authors>Kim C</pubmed_authors><pubmed_authors>Agidigbi TS</pubmed_authors><pubmed_authors>Choi EB</pubmed_authors><pubmed_authors>Kang IS</pubmed_authors></additional><is_claimable>false</is_claimable><name>ERK Inhibition Increases RANKL-Induced Osteoclast Differentiation in RAW 264.7 Cells by Stimulating AMPK Activation and RANK Expression and Inhibiting Anti-Osteoclastogenic Factor Expression.</name><description>Bone absorption is necessary for the maintenance of bone homeostasis. An osteoclast (OC) is a monocyte-macrophage lineage cell that absorbs bone tissue. Extracellular signal-regulated kinases (ERKs) are known to play important roles in regulating OC growth and differentiation. In this study, we examined specific downstream signal pathways affected by ERK inhibition during OC differentiation. Our results showed that the ERK inhibitors PD98059 and U0126 increased receptor activator of NF-κB ligand (RANKL)-induced OC differentiation in RAW 264.7 cells, implying a negative role in OC differentiation. This is supported by the effect of ERK2-specific small interfering RNA on increasing OC differentiation. In contrast to our findings regarding the RAW 264.7 cells, the ERK inhibitors attenuated th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-25T23:40:32.738Z</modification><creation>2025-04-06T09:25:37.731Z</creation></dates><accession>S-EPMC9656104</accession><cross_references><pubmed>36362318</pubmed><doi>10.3390/ijms232113512</doi></cross_references></HashMap>